FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

10 results

argatroban
(Argatroban)
Par Pharmaceutical, Inc.
Usage: Argatroban Injection is indicated for the prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia (HIT), and as an anticoagulant in those with or at risk for HIT undergoing percutaneous coronary intervention (PCI).
argatroban
(Argatroban)
Par Pharmaceutical, Inc.
Usage: Argatroban Injection is indicated for the prophylaxis or treatment of thrombosis in adults with heparin-induced thrombocytopenia (HIT) and as an anticoagulant during percutaneous coronary interventions (PCI) in patients with or at risk for HIT.
argatroban
(Argatroban)
Gland Pharma Limited
Usage: Argatroban Injection is indicated for the prophylaxis or treatment of thrombosis in adults with heparin-induced thrombocytopenia (HIT) and as an anticoagulant for those with or at risk for HIT undergoing percutaneous coronary intervention (PCI).
argatroban
(Argatroban)
Amneal Pharmaceuticals LLC
Usage: Argatroban injection is indicated for the prophylaxis or treatment of thrombosis in adults with heparin-induced thrombocytopenia (HIT) and as an anticoagulant in patients with HIT undergoing percutaneous coronary intervention (PCI).
argatroban
(Argatroban)
Hikma Pharmaceuticals USA Inc.
Usage: Argatroban Injection is indicated for the prophylaxis or treatment of thrombosis in adults with heparin-induced thrombocytopenia (HIT) and as an anticoagulant for those undergoing percutaneous coronary intervention (PCI) who are at risk for HIT.
bivalirudin
(bivalirudin)
Accord Healthcare, Inc.
Usage: Bivalirudin for injection is indicated as an anticoagulant for patients undergoing percutaneous coronary intervention (PCI), including those with heparin-induced thrombocytopenia and thrombosis syndrome.
eptifibatide
(Eptifibatide)
Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Usage: Eptifibatide injection is indicated to reduce the risk of death or new myocardial infarction in patients with acute coronary syndrome (ACS) and to decrease the rate of adverse outcomes in patients undergoing percutaneous coronary intervention (PCI), including those receiving intracoronary stenting.
eptifibatide
(eptifibatide)
Sagent Pharmaceuticals
Usage: Eptifibatide Injection is indicated for the management of Acute Coronary Syndrome (ACS) to reduce the risk of death or new myocardial infarction. It is also used during Percutaneous Coronary Intervention (PCI) to lower the rates of death, new MI, or the need for urgent intervention.
eptifibatide
(eptifibatide)
Mylan Institutional LLC
Usage: Eptifibatide injection is indicated for reducing the risk of death or new myocardial infarction in patients with acute coronary syndrome (ACS) and for decreasing complications in patients undergoing percutaneous coronary intervention (PCI), including those receiving intracoronary stenting.
eptifibatide
(Eptifibatide)
Eugia US LLC
Usage: Eptifibatide injection is indicated for reducing the risk of death or new myocardial infarction in patients with acute coronary syndrome (ACS) and to decrease adverse outcomes during percutaneous coronary intervention (PCI), including those undergoing intracoronary stenting.

Medications for Percutaneous Coronary Intervention

argatroban

argatroban

argatroban

argatroban

argatroban

bivalirudin

eptifibatide

eptifibatide

eptifibatide

eptifibatide